Diclofenac Potassium Powder, For Solution
Product Images NDC 31722-046

6 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diclofenac Potassium (NDC 31722-046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diclofenacoscartonlabel50mg (Diclofenacoscartonlabel50mg)

Diclofenacoscartonlabel50mg (Diclofenacoscartonlabel50mg)
Packaging label for Diclofenac Potassium for Oral Solution 50 mg powder for solution by Camber Pharmaceuticals, Inc. The label includes NDC 31722-046-32 and instructions for use, storage conditions (20° to 25°C), and inactive ingredients. It indicates the product comes in nine packets total, with directions to mix with water only. Contact information and manufacturer details for Camber Pharmaceuticals and Annora Pharma Pvt. Ltd. are also shown.*
FDA Label Image

Diclofenacossachetlabel-50-mg (Diclofenacossachetlabel 50 mg)

Diclofenacossachetlabel-50-mg (Diclofenacossachetlabel 50 mg)
Label for Diclofenac Potassium Oral Solution, 50 mg, powder for solution produced by Camber Pharmaceuticals, Inc. The label includes directions for opening the unit dose packet and provides storage information. It features the product name with strength prominently displayed in red, a barcode, and an area designated for batch coding.*
FDA Label Image

Diclofenacosscamberlogo1 (Diclofenacosscamberlogo1)

FDA Label Image

Diclofenacosscamberlogo2 (Diclofenacosscamberlogo2)

FDA Label Image

Diclofenacossfig1 (Diclofenacossfig1)

Diclofenacossfig1 (Diclofenacossfig1)
A line graph comparing the percent of subjects over time (in hours) between Diclofenac potassium and placebo groups. The x-axis shows hours from 0 to 2.25, and the y-axis shows percent of subjects up to 30%. Two plotted lines represent Diclofenac potassium and placebo, with Diclofenac potassium line generally higher across the time points.*
FDA Label Image

Diclofenacosstructure (Diclofenacosstructure)

Diclofenacosstructure (Diclofenacosstructure)
Chemical structure of diclofenac potassium, showing two benzene rings with chlorine substitutions, an amine linkage, and a potassium carboxylate group, consistent with the active ingredient in the product Diclofenac potassium 50 mg powder for solution oral.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.